Physician profile
Fei Wang
NPI 1700535796
$7,088.36
in general payments reported to CMS, 2019-2025
18 companies · $2,785 in 2025
The $2,785 reported for 2025 was more than what 96% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $517 · 2023: $1,042 · 2024: $2,744 · 2025: $2,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,571.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,736.83 | 2022-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $1,342.89 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Teva Pharmaceuticals USA, INC. | $820.30 | 2022-2024 | Austedo Xr, Uzedy, Ajovy |
| Novo Nordisk INC | $609.22 | 2023-2025 | Wegovy, Ozempic |
| Phathom Pharmaceuticals, INC. | $392.96 | 2024-2025 | Voquezna |
| Dexcom, INC. | $284.16 | 2024-2025 | Dexcom G6 Transmitter |
| Scilex Pharmaceuticals INC. | $277.16 | 2024 | |
| Abbvie INC. | $250.00 | 2022-2023 | |
| Vanda Pharmaceuticals INC. | $250.00 | 2024-2025 | Fanapt |
| Abbott Laboratories | $159.13 | 2025 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $150.00 | 2024 | Epclusa |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Rexulti |
| Aimmune Therapeutics, INC. | $125.00 | 2025 | Zenpep |
| Ardelyx, INC. | $125.00 | 2025 | Ibsrela |
| Insulet Corporation | $124.99 | 2023 | Omnipod |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $111.73 | 2025 | Cequr Simplicity |
| Idorsia Pharmaceuticals US INC | $104.00 | 2022-2023 | Quviviq |
| Antares Pharma, INC. | $99.99 | 2023 | Xyosted, Tlando, Nocdurna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fei Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.